Cotta Filho, Cezar Kayzuka; Oliveira-Paula, Gustavo Henrique; Pereira, Vitória Carolina Rondon; Lacchini, Riccardo 
Source: Expert Opinion on Drug Metabolism & Toxicology. Unidades: FMRP, EERP
Subjects: ÓXIDO NÍTRICO, FARMACOGENÉTICA, POLIMORFISMO, ALELOS, PREDISPOSIÇÃO GENÉTICA PARA DOENÇA, NUCLEOTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COTTA FILHO, Cezar Kayzuka et al. Clinically relevant endothelial nitric oxide synthase polymorphisms and their impact on drug response. Expert Opinion on Drug Metabolism & Toxicology, v. 16, n. 10, p. 927-951, 2020Tradução . . Disponível em: https://doi.org/10.1080/17425255.2020.1804857. Acesso em: 12 nov. 2024.APA
Cotta Filho, C. K., Oliveira-Paula, G. H., Pereira, V. C. R., & Lacchini, R. (2020). Clinically relevant endothelial nitric oxide synthase polymorphisms and their impact on drug response. Expert Opinion on Drug Metabolism & Toxicology, 16( 10), 927-951. doi:10.1080/17425255.2020.1804857NLM
Cotta Filho CK, Oliveira-Paula GH, Pereira VCR, Lacchini R. Clinically relevant endothelial nitric oxide synthase polymorphisms and their impact on drug response [Internet]. Expert Opinion on Drug Metabolism & Toxicology. 2020 ; 16( 10): 927-951.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1080/17425255.2020.1804857Vancouver
Cotta Filho CK, Oliveira-Paula GH, Pereira VCR, Lacchini R. Clinically relevant endothelial nitric oxide synthase polymorphisms and their impact on drug response [Internet]. Expert Opinion on Drug Metabolism & Toxicology. 2020 ; 16( 10): 927-951.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1080/17425255.2020.1804857
